Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis

Goh Eun Chung, Donghee Kim

Clin Mol Hepatol. 2013;19(2):116-119. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.116

View: 6951 Download: 91

The Korean Journal of Hepatology Elsewhere

Apoptosis and diagnosis of nonalcoholic steatohepatitis

Chang Wook Kim, Chang Don Lee

Clin Mol Hepatol. 2011;17(3):247-249. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.247

View: 6115 Download: 44 Crossref: 1

Original Article

The effect of preconditioning on liver regeneration after hepatic resection in cirrhotic rats

Seon Ok Min, Sung Hoon Kim, Sang Woo Lee, Jin A Cho, Kyung Sik Kim

Clin Mol Hepatol. 2011;17(2):139-147. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.139

View: 7479 Download: 37 Crossref: 2

2

Pro-apoptotic function of hepatitis B virus X protein

Kyun-Hwan Kim, Ph.D.

Clin Mol Hepatol. 2010;16(2):112-122. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.112

View: 6752 Download: 40 Crossref: 2

3

Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor

Il Han Song, M.D., Dong Woo Kim, M.D., Ki Chul Shin, M.D., Hyun Duk Shin, M.D., Se Young Yun, M.D., Suk Bae Kim, M.D., Jung Eun Shin, M.D., Hong Ja Kim, M.D., Eun Young Kim, M.D.

Clin Mol Hepatol. 2008;14(3):351-359. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.351

View: 4106 Download: 24 Crossref: 4

1

Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitor

Jeong Won Jang

Clin Mol Hepatol. 2008;14(3):305-308. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.305

View: 3902 Download: 19 Crossref: 4

2

Cerulein Pancreatitis: Oxidative Stress, Inflammation, and Apoptosis

Hye Young Kim

Clin Mol Hepatol. 2008;12(2):74-80.

View: 1958 Download: 12

3

Prostaglandin A₂ Induces Caspase-independent Apoptosis in Hepatocellular Carcinoma Cells

Ho Shik Kim , Jae Chun Shim , Ju Youn Choi , Hyang Shuk Rhim , In Kyung Kim

Clin Mol Hepatol. 2005;11(1):72-79. Published online January 1, 2000

View: 2226 Download: 12

7

Il Han Song

Clin Mol Hepatol. 2004;10(2):174-176. Published online January 1, 1970

View: 2341 Download: 14

Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 2003;37: 87-95

Geun Youn Gwok , Jung Hwan Yoon

Clin Mol Hepatol. 2003;9(2):145-146. Published online January 1, 1970

View: 2363 Download: 18

3

The mRNA Expression of Tumor Necrosis Factor - Related Apoptosis - Inducing Ligand (TRAIL) and Its Receptors in Hepatocellular Carcinoma and Surrounding Liver Tissues

Saera Jung, M.D., Han Chu Lee, M.D., Hee Gon Song, M.D., Young-Hwa Chung, M.D., Yung Sang Lee, M.D., Ghil-Sook Yoon, M.D.*, Eunsil Yu, M.D.*, and Dong Jin Suh, M.D.

Clin Mol Hepatol. 2001;7(3):273-280. Published online January 1, 2000

View: 2150 Download: 13

Protective Effect of Cholesteryl Hemisuccinate on Fumonisin B1-Induced Apoptosis of Hepatocytes in the Rat Liver

Woo Sung Moon, M.D. Chul Kyu Park, M.D. Myoung Jae Kang, M. D. Dong Geun Lee, M.D. Ho Yeul Choi, M.D.

Clin Mol Hepatol. 1999;5(3):227-239. Published online January 1, 2000

View: 2129 Download: 13

Analysis of Cell Proliferative Activity , p53 Protein Overexpression and Apoptosis in Hepatocellular Carcinoma and Surrounding Nontumorous Liver

So Dug Lim , Woo Ho Kim , Ja June Jang , Eun Sil Yu

Clin Mol Hepatol. 1998;4(1):33-45.

View: 2175 Download: 12

1 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5409	MAFLD: How is it different from NAFLD?
Viewed By 5220	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5098	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search